ES2664194T3 - Método novedoso para la producción de células diferenciadas - Google Patents
Método novedoso para la producción de células diferenciadas Download PDFInfo
- Publication number
- ES2664194T3 ES2664194T3 ES10817186.9T ES10817186T ES2664194T3 ES 2664194 T3 ES2664194 T3 ES 2664194T3 ES 10817186 T ES10817186 T ES 10817186T ES 2664194 T3 ES2664194 T3 ES 2664194T3
- Authority
- ES
- Spain
- Prior art keywords
- cells
- myc
- bmi1
- results
- analysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- 238000000034 method Methods 0.000 title description 2
- 210000004027 cell Anatomy 0.000 abstract description 40
- 101000872170 Homo sapiens Polycomb complex protein BMI-1 Proteins 0.000 abstract description 16
- 230000014509 gene expression Effects 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 abstract description 10
- 210000003593 megakaryocyte Anatomy 0.000 abstract description 5
- 210000003958 hematopoietic stem cell Anatomy 0.000 abstract description 3
- 230000001939 inductive effect Effects 0.000 abstract description 3
- 210000002361 Megakaryocyte Progenitor Cell Anatomy 0.000 abstract description 2
- 108700020796 Oncogene Proteins 0.000 abstract description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 abstract 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 abstract 1
- 108091057508 Myc family Proteins 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 102100033566 Polycomb complex protein BMI-1 Human genes 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 9
- 230000004069 differentiation Effects 0.000 description 7
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 4
- 230000004913 activation Effects 0.000 description 3
- 210000001671 embryonic stem cell Anatomy 0.000 description 3
- 229960005309 estradiol Drugs 0.000 description 3
- 102000006495 integrins Human genes 0.000 description 3
- 108010044426 integrins Proteins 0.000 description 3
- 101150062914 BMI1 gene Proteins 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 101150085741 Hoxa2 gene Proteins 0.000 description 1
- 102100025306 Integrin alpha-IIb Human genes 0.000 description 1
- 102000008607 Integrin beta3 Human genes 0.000 description 1
- 108010020950 Integrin beta3 Proteins 0.000 description 1
- 101100058550 Mus musculus Bmi1 gene Proteins 0.000 description 1
- 108010035030 Platelet Membrane Glycoprotein IIb Proteins 0.000 description 1
- 102100034173 Platelet glycoprotein Ib alpha chain Human genes 0.000 description 1
- 101710107770 Platelet glycoprotein Ib alpha chain Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0641—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0644—Platelets; Megakaryocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/48—Regulators of apoptosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/606—Transcription factors c-Myc
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Developmental Biology & Embryology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009213645 | 2009-09-15 | ||
| JP2009213645 | 2009-09-15 | ||
| PCT/JP2010/065903 WO2011034073A1 (ja) | 2009-09-15 | 2010-09-15 | 分化細胞の新規製造法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2664194T3 true ES2664194T3 (es) | 2018-04-18 |
Family
ID=43758674
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10817186.9T Active ES2664194T3 (es) | 2009-09-15 | 2010-09-15 | Método novedoso para la producción de células diferenciadas |
| ES16202612T Active ES2725688T3 (es) | 2009-09-15 | 2010-09-15 | Método novedoso para la producción de células diferenciadas |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES16202612T Active ES2725688T3 (es) | 2009-09-15 | 2010-09-15 | Método novedoso para la producción de células diferenciadas |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9200254B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3159001B1 (cg-RX-API-DMAC7.html) |
| JP (4) | JP5791191B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR101834687B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN102712906B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010296415B2 (cg-RX-API-DMAC7.html) |
| BR (2) | BR112012005710B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2774193C (cg-RX-API-DMAC7.html) |
| DK (2) | DK2500418T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2664194T3 (cg-RX-API-DMAC7.html) |
| IN (1) | IN2012DN02642A (cg-RX-API-DMAC7.html) |
| RU (2) | RU2661107C1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011034073A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5861191B2 (ja) * | 2010-09-30 | 2016-02-16 | 国立大学法人 熊本大学 | ミエロイド系血液細胞の製造方法 |
| JP5824760B2 (ja) | 2011-05-13 | 2015-12-02 | 国立大学法人 東京大学 | 多核化巨核球細胞、及び血小板の製造方法 |
| RU2014117642A (ru) | 2011-10-03 | 2015-11-10 | Ниссан Кемикал Индастриз, Лтд. | Способ получения мегакариоцитов и/или тромбоцитов из плюрипотентных стволовых клеток |
| GB201210857D0 (en) | 2012-06-19 | 2012-08-01 | Cambridge Entpr Ltd | Transcription factor mediated programming towards megakaryocytes |
| WO2014100779A1 (en) | 2012-12-21 | 2014-06-26 | Advanced Cell Technology, Inc. | Methods ofr production of platelets from pluripotent stem cells and compositions thereof |
| EP2955223B1 (en) * | 2013-02-08 | 2019-12-18 | Kyoto University | Production methods for megakaryocytes and platelets |
| WO2014168255A1 (ja) * | 2013-04-12 | 2014-10-16 | 国立大学法人京都大学 | 巨核球の成熟化促進物質 |
| EP2987852A4 (en) | 2013-04-17 | 2016-09-07 | Nissan Chemical Ind Ltd | MEDIA COMPOSITION AND METHOD FOR THE PRODUCTION OF ERYTHROCYTES THEREWITH |
| EP3760711A1 (en) * | 2013-05-15 | 2021-01-06 | University Of Rochester | Human extensively self-renewing erythroblasts (esre) |
| US10112977B2 (en) | 2014-06-23 | 2018-10-30 | Toagosei Co., Ltd. | Peptide for inducing multinucleation in cells, and use therefor |
| KR20180015613A (ko) | 2015-03-09 | 2018-02-13 | 가부시키가이샤 메가카리온 | 거핵구를 포함하는 배양물의 제조 방법 및 이를 사용한 혈소판의 제조 방법 |
| CA2982568A1 (en) * | 2015-04-14 | 2016-10-20 | Kyoto University | Method for producing stem cell clone suitable for inducing differentiation into somatic cells |
| KR20160129609A (ko) | 2015-04-30 | 2016-11-09 | 삼성전자주식회사 | Ｂｒａｆ 저해제를 포함하는 세포 또는 개체의 노화를 감소시키기 위한 조성물 및 그의 용도 |
| JP6856537B2 (ja) * | 2015-11-02 | 2021-04-07 | 株式会社メガカリオン | 往復動撹拌装置を用いた血小板の製造方法および血小板の製造に用いられる培養容器 |
| WO2017131230A1 (ja) | 2016-01-29 | 2017-08-03 | 国立大学法人京都大学 | 血小板産生促進剤及びそれを用いた血小板の製造方法 |
| WO2017131228A1 (ja) | 2016-01-29 | 2017-08-03 | 国立大学法人京都大学 | 血小板産生促進剤のスクリーニング方法 |
| JP7297203B2 (ja) | 2017-03-06 | 2023-06-26 | 国立大学法人京都大学 | 血小板の製造方法 |
| FR3068366B1 (fr) * | 2017-06-30 | 2023-11-24 | Francais Du Sang Ets | Procede de production de progeniteurs erythroides |
| EP3650535A4 (en) | 2017-07-07 | 2021-03-17 | Kyoto University | PROCESS AND APPARATUS FOR THE PRODUCTION OF PLATES AND METHOD FOR DETERMINING OPERATING CONDITIONS IN AN APPARATUS FOR THE PRODUCTION OF PLATES |
| WO2019059235A1 (ja) | 2017-09-19 | 2019-03-28 | 株式会社メガカリオン | 精製血小板の製造方法、血小板製剤の製造方法、血液製剤の製造方法、血小板保存液、血小板保存剤および血小板の保存方法 |
| JP7160353B2 (ja) | 2017-09-19 | 2022-10-25 | 株式会社メガカリオン | 血小板の製造方法、血小板製剤の製造方法、および血液製剤の製造方法 |
| MX2020007071A (es) | 2018-01-05 | 2020-11-11 | Platelet Biogenesis Inc | Composiciones y metodos para producir megacariocitos. |
| WO2020006539A1 (en) | 2018-06-29 | 2020-01-02 | Platelet Biogenesis, Inc. | Compositions for drug delivery and methods of use thereof |
| TW202045202A (zh) * | 2019-02-25 | 2020-12-16 | 國立陽明大學 | 用於治療肺纖維化和肺氣腫的組合物及其使用方法 |
| CA3138298A1 (en) * | 2019-05-01 | 2020-11-05 | Transfusion Health, Llc | Methods of making oligopotent and unipotent precursors |
| WO2021117886A1 (ja) | 2019-12-12 | 2021-06-17 | 国立大学法人千葉大学 | 巨核球および血小板を含む凍結乾燥製剤 |
| WO2021117900A1 (ja) | 2019-12-13 | 2021-06-17 | 株式会社メガカリオン | 組成物およびその用途 |
| CN116437940A (zh) | 2020-10-27 | 2023-07-14 | 国立大学法人长崎大学 | 骨形成组合物和其用途 |
| JP7716851B2 (ja) * | 2020-12-28 | 2025-08-01 | イビデン株式会社 | 凍結保存液 |
| WO2022265117A1 (ja) | 2021-06-18 | 2022-12-22 | 株式会社メガカリオン | 血小板産生能が増強された多核化巨核球細胞の製造方法、血小板の製造方法、血小板製剤の製造方法、および血液製剤の製造方法 |
| WO2023277153A1 (ja) | 2021-06-30 | 2023-01-05 | 国立大学法人千葉大学 | 骨髄系共通前駆細胞（ｃｍｐ）又は骨髄球系前駆細胞の増殖性を向上させる方法 |
| WO2024010317A1 (ko) * | 2022-07-04 | 2024-01-11 | 주식회사 아트블러드 | 유전자 과발현 조합을 이용한 적혈구 분화능이 우수한 불멸화 적혈구전구세포주 확립, 이의 제조방법 및 용도 |
| JP2025534107A (ja) | 2022-10-18 | 2025-10-09 | ソングァン メディカル ファンデーション | 幹細胞から血小板前駆細胞への分化誘導用培地組成物及びそれを用いた分化方法 |
| JPWO2024143555A1 (cg-RX-API-DMAC7.html) | 2022-12-28 | 2024-07-04 | ||
| JPWO2024210126A1 (cg-RX-API-DMAC7.html) | 2023-04-03 | 2024-10-10 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US572333A (en) | 1896-12-01 | Evaporating apparatus | ||
| JPH06508749A (ja) | 1991-06-28 | 1994-10-06 | ニュー イングランド ディーコネス ホスピタル | 新規な巨核球分化因子を産生する分化した巨核球の一系統 |
| GB9502022D0 (en) * | 1995-02-02 | 1995-03-22 | Abuljadayel Ilham M S | A method for preparing lymphohaematopoietic progenitor cells |
| US5723333A (en) | 1995-02-10 | 1998-03-03 | Regents Of The University Of California | Human pancreatic cell lines: developments and uses |
| WO1996024669A1 (en) | 1995-02-10 | 1996-08-15 | The Regents Of The University Of California | Human pancreatic cell lines: developments and uses |
| US20050159378A1 (en) * | 2001-05-18 | 2005-07-21 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA) |
| WO2004029208A2 (en) * | 2002-09-27 | 2004-04-08 | Bioe, Inc. | Cell separation compositions and methods |
| JP3896482B2 (ja) * | 2002-10-07 | 2007-03-22 | 独立行政法人産業技術総合研究所 | 分化細胞の作製方法 |
| JP2004350601A (ja) | 2003-05-29 | 2004-12-16 | Tanabe Seiyaku Co Ltd | 霊長類動物の胚性幹細胞から造血系細胞への分化方法 |
| JP4706208B2 (ja) | 2004-08-27 | 2011-06-22 | 株式会社アイル | 造血幹細胞の製造方法 |
| JP2006141356A (ja) | 2004-11-24 | 2006-06-08 | Institute Of Physical & Chemical Research | Ｅｓ細胞から樹立された造血幹細胞 |
| IL286053B2 (en) * | 2005-10-18 | 2023-03-01 | Nat Jewish Health | A process for making red blood cells using immortal hematopoietic stem cells and erythropoietin |
| AU2006311637A1 (en) * | 2005-11-07 | 2007-05-18 | The General Hospital Corporation | Methods and compositions for modulation of stem cell aging |
| CN101864392B (zh) * | 2005-12-13 | 2016-03-23 | 国立大学法人京都大学 | 核重新编程因子 |
| US8058064B2 (en) | 2006-10-04 | 2011-11-15 | The University Of Tokyo | Sac-like structure enclosing hematopoietic progenitor cells produced from ES cells and method for preparing blood cells |
| AU2008297024B2 (en) | 2007-10-31 | 2014-08-28 | Kyoto University | Nuclear reprogramming method |
| CN101492676B (zh) * | 2008-09-16 | 2011-02-16 | 中国科学院广州生物医药与健康研究院 | 用脑膜细胞生成诱导的多能性干细胞的方法及其用途 |
-
2010
- 2010-09-15 KR KR1020167027550A patent/KR101834687B1/ko active Active
- 2010-09-15 BR BR112012005710A patent/BR112012005710B1/pt active IP Right Grant
- 2010-09-15 EP EP16202612.4A patent/EP3159001B1/en active Active
- 2010-09-15 RU RU2016139042A patent/RU2661107C1/ru active
- 2010-09-15 ES ES10817186.9T patent/ES2664194T3/es active Active
- 2010-09-15 US US13/496,321 patent/US9200254B2/en active Active
- 2010-09-15 RU RU2012114427/10A patent/RU2603094C2/ru active
- 2010-09-15 WO PCT/JP2010/065903 patent/WO2011034073A1/ja not_active Ceased
- 2010-09-15 ES ES16202612T patent/ES2725688T3/es active Active
- 2010-09-15 DK DK10817186.9T patent/DK2500418T3/en active
- 2010-09-15 CN CN201080042161.7A patent/CN102712906B/zh active Active
- 2010-09-15 CA CA2774193A patent/CA2774193C/en active Active
- 2010-09-15 BR BR122013008030A patent/BR122013008030B8/pt active IP Right Grant
- 2010-09-15 DK DK16202612.4T patent/DK3159001T3/da active
- 2010-09-15 CN CN201510530896.9A patent/CN105385659B/zh not_active Expired - Fee Related
- 2010-09-15 KR KR1020127009225A patent/KR101667834B1/ko active Active
- 2010-09-15 AU AU2010296415A patent/AU2010296415B2/en active Active
- 2010-09-15 IN IN2642DEN2012 patent/IN2012DN02642A/en unknown
- 2010-09-15 EP EP10817186.9A patent/EP2500418B1/en active Active
- 2010-09-15 JP JP2011531940A patent/JP5791191B2/ja active Active
-
2015
- 2015-02-13 JP JP2015026547A patent/JP2015130866A/ja active Pending
- 2015-08-03 JP JP2015153048A patent/JP6265437B2/ja active Active
- 2015-10-28 US US14/925,508 patent/US10087419B2/en active Active
-
2016
- 2016-11-29 JP JP2016231020A patent/JP6382917B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2664194T3 (es) | Método novedoso para la producción de células diferenciadas | |
| McGuckin et al. | Culture of embryonic-like stem cells from human umbilical cord blood and onward differentiation to neural cells in vitro | |
| AR132549A2 (es) | Medio de cultivo para células cho libre de suero que comprende ornitina y putrescina, método para cultivar células cho y método in vitro para producir una proteína | |
| Sisakhtnezhad et al. | External factors influencing mesenchymal stem cell fate in vitro | |
| Frum et al. | hPSC-derived organoids: models of human development and disease | |
| BR112021007748A2 (pt) | métodos e sistemas para fabricar células de linhagem hematopoiética | |
| JP6510033B2 (ja) | 三次元複合細胞凝集体モデル並びにその製造方法及び応用 | |
| US20240301348A1 (en) | Small mobile stem cells (sms) and uses thereof | |
| CN113151149B (zh) | 一种诱导肺类器官的方法及实验模型的建立 | |
| Benda et al. | Urine as a source of stem cells | |
| ES2978902T3 (es) | Método para fabricar células madre pluripotentes inducidas a partir de células madre mesenquimatosas derivadas de tejido adiposo y las células madre pluripotentes inducidas fabricadas mediante dicho método | |
| JP6721868B2 (ja) | スフェロイドの作製方法及び該方法に用いる培地 | |
| Cortez et al. | Bovine adipose tissue-derived mesenchymal stem cells self-assemble with testicular cells and integrates and modifies the structure of a testicular organoids | |
| JP2024521447A (ja) | 複数の嚢胞を含む大型細胞微小区画 | |
| CN101089176A (zh) | 一种干细胞分离液及其用于干细胞分离的方法 | |
| JP2010531146A (ja) | 変温脊椎動物の成体組織からの幹細胞の特性を有する単離された増殖細胞，その安定な細胞培養，及びその調製のための方法 | |
| US20250223558A1 (en) | Large scale manufacturing of ipsc derived hsc and progeny | |
| KR102142254B1 (ko) | 3,4''-다이하이드록시플라본을 이용한 소변줄기세포의 분리 효율 향상 및 소변줄기세포유래 만능줄기세포의 조혈줄기세포 분화 효율을 촉진시키는 방법 | |
| Arutyunyan et al. | Effect of endothelial cells on angiogenic properties of multipotent stromal cells from the umbilical cord during angiogenesis modeling in the basement membrane matrix | |
| CN103642689A (zh) | 一种哺乳动物胚胎的体外微动态培养装置及用其培养胚胎的方法 | |
| Ikeda et al. | 3D culture of mouse iPSCs in hydrogel core-shell microfibers | |
| CN103266085B (zh) | 哺乳动物多潜能干细胞外源基因高效转染及快速筛选 | |
| ES2386311T3 (es) | Uso de anticuerpos anti glicoproteína ACA para obtener/mantener células madre pluripotentes no embrionarias | |
| CN103232970B (zh) | 一种利用三维序贯共培养进行胚胎体外培养的方法 | |
| Cananzi et al. | Stem cells from amniotic fluid |